Ligand Pharmaceuticals | LGND - Zahlungsmittel Und Äquivalente

Aktienkurs
225.06
Täglich Wechseln
-7.26 -3.13%
Monatlich
16.83%
Jährlich
104.86%
Q2 Prognose
226.32




Zahlungsmittel Und Äquivalente Veränderung Datum
Agenus USD 3.46M 6.08M 2025-09
Amgen USD 9.13B 316M 2025-12
Anika Therapeutics USD 57.48M 509K 2025-12
Arrowhead Research USD 201.64M 112.94M 2025-12
Baxter International USD 1.97B 240M 2025-12
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
Eli Lilly USD 7.27B 2.52B 2025-12
Enanta Pharmaceuticals USD 37.44M 5.14M 2025-12
Enviri Corporation USD 103.67M 11.69M 2025-12
Gilead Sciences USD 7.56B 234M 2025-12
GlaxoSmithKline GBP 3.15B 146M 2025-12
Glaxosmithkline GBP 3.3B 303M 2025-09
Heron Therapeutics USD 43.07M 26.55M 2025-09
Insmed USD 510.44M 175.68M 2025-12
Intrexon USD 9.34M 1.77M 2024-06
Ionis Pharmaceuticals USD 1.92B 758M 2026-03
Karyopharm Therapeutics USD 60.54M 22.87M 2025-12
Ligand Pharmaceuticals USD 174.93M 489.59M 2025-12
MacroGenics USD 57.22M 22.91M 2025-12
Merck USD 18.17B 10.16B 2025-09
Pacira USD 158.54M 10.96M 2025-12
Pfizer USD 1.34B 295M 2025-09
Rigel Pharmaceuticals USD 48.53M 4.87M 2025-09
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Veracyte USD 362.58M 47M 2025-12